Skip to main content
TipRanks
Go Ultimate75% OFF

Royalty Pharma (RPRX) Q4 2023 Earnings Report

1,359 Followers

RPRX Q4 2023 EPS Results

Actual EPS
$1.15
Consensus EPS
$1.01
Beat/Miss
Beat by +$0.14
One Year Ago EPS
$1.56

RPRX Q4 2023 Revenue Results

Actual Revenue
$596.00M
Expected Revenue
$685.52M
Beat/Miss
Missed by -$89.52M
YoY Revenue Growth
+5.30%

Earnings Announcement Details

Quarter
Q4 2023
Date
02/15/2024
Time
Before Open
Conference Call
Thursday, February 15, 2024
RPRX Upcoming Earnings

Royalty Pharma's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

RPRX Q4 2023 Earnings Call
0:00 / 0:00

Q4 2023 Earnings Slide Deck

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

RPRX Earnings History

RPRX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 16, 20272026 (Q4)1.58-1.47――
Nov 04, 20262026 (Q3)1.181.211.172.98% (+0.04)
Aug 05, 20262026 (Q2)1.271.321.1415.78% (+0.18)
May 06, 20262026 (Q1)1.211.300.7573.03% (+0.55)
Feb 11, 20262025 (Q4)1.291.471.1527.37% (+0.32)
Nov 05, 20252025 (Q3)0.991.170.9227.92% (+0.26)
Aug 06, 20252025 (Q2)1.031.140.9618.73% (+0.18)
May 08, 20252025 (Q1)0.950.750.98-23.42% (-0.23)
Feb 11, 20252024 (Q4)1.051.151.150.17% (+0.00)
Nov 06, 20242024 (Q3)0.930.920.7916.22% (+0.13)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed